https://www.selleckchem.com/pr....oducts/alflutinib-as
Bipolar disorder (BD) has high clinical heterogeneity, frequent psychiatric comorbidities, and elevated suicide risk. To determine genetic differences between common clinical sub-phenotypes of BD, we performed a systematic polygenic risk score (PRS) analysis using multiple PRSs from a range of psychiatric, personality, and lifestyle traits to dissect differences in BD sub-phenotypes in two BD cohorts the Mayo Clinic BD Biobank (N = 968) and Genetic Association Information Network (N = 1001). Participants were assesse
Like
Comment
Share
